source
- Iambic Therapeutics raises $150 million in IPO to fund oncology drug developmentIambic Therapeutics, a San Diego-based AI biotech, completed an initial public offering that raised $150 million, exactly meeting its goal of selling 9.4 million shares at $16 each. The company sa…
- IQVIA urges early clinical insight in drug discovery to boost patient benefitIQVIA Laboratories' leaders argue that drug discovery and clinical development should be linked early to improve patient outcomes. They explain that decisions made during discovery affect later cl…